Phocas Financial Corp. Coherus Bio Sciences, Inc. Transaction History

Phocas Financial Corp.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$3.79 - $8.3 $494,208 - $1.08 Million	130,398 Added 79.93%	293,538 $1.25 Million
Q1 2023 Apr 13, 2023	BUY	$5.89 - $10.52 $960,894 - $1.72 Million	163,140 New	163,140 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$5.86 - $13.23 $395,872 - $893,752	-67,555 Reduced 17.59%	316,455 $2.29 Million
Q1 2022 May 25, 2022	SELL	$10.92 - $16.41 $1.42 Million - $2.14 Million	-130,428 Reduced 25.35%	384,010 $4.96 Million
Q4 2021 Feb 15, 2022	BUY	$15.81 - $18.99 $150,226 - $180,442	9,502 Added 1.88%	514,438 $8.21 Million
Q3 2021 Nov 16, 2021	BUY	$12.68 - $17.79 $3.22 Million - $4.51 Million	253,578 Added 100.88%	504,936 $8.11 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $644,003 - $766,339	49,730 Added 24.66%	251,358 $3.48 Million
Q1 2021 Jun 22, 2021	BUY	$14.42 - $21.39 $1.43 Million - $2.12 Million	99,013 Added 96.49%	201,628 $2.95 Million
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $345,226 - $394,842	-20,847 Reduced 16.89%	102,615 $1.78 Million
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $68,699 - $78,485	3,946 Added 3.3%	123,462 $2.26 Million
Q2 2020 Aug 24, 2020	SELL	$14.43 - $19.16 $149,249 - $198,171	-10,343 Reduced 7.96%	119,516 $2.13 Million
Q1 2020 May 15, 2020	BUY	$11.67 - $22.53 $190,349 - $367,486	16,311 Added 14.36%	129,859 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $1.85 Million - $2.43 Million	113,548 New	113,548 $2.04 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.